CHMP recommends six new drugs

The European Medicines Agency's committee has at its October meeting recommended six drugs for market approval in Europe. In addition, the authority recommends new uses for ten other drugs.

Patients with type 2 diabetes or atopic dermatitis are among those who will have more treatment options going foward.

During the monthly meeting of the EU Committee for Medicinal Products for Human Use (CHMP), which is responsible for preparing the Agency's opinions on future drugs, treatments for these diseases have seen their EU market approval recommended.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs